Kostas Kaloulis
Investitore di Private Equity presso NanoDimension Management Ltd.
Provenienza dei contatti di primo grado di Kostas Kaloulis
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
50
| Public Company | Pharmaceuticals: Major | 50 |
NanoDimension Management Ltd.
 NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town.
17
| Private Company | Investment Managers | 17 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kostas Kaloulis tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Chairman Director/Board Member Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President Human Resources Officer Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Verband der Chemischen Industrie eV
 Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Vandria SA
 Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer | |
| Swiss Federal Institute of Technology | College/University | President Graduate Degree Director/Board Member | |
| Stanford University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University School of Medicine | College/University | Graduate Degree Doctorate Degree | |
| Procom RX | Chairman Chief Executive Officer | ||
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member Director/Board Member | |
Merck Millipore Corp.
 Merck Millipore Corp. Miscellaneous Commercial ServicesCommercial Services Merck Millipore Corp. provides biotechnological research and development services. It offers for antibodies, organic compounds, proteins and enzymes complexes, inhibitors, capsule filter, cartridge filters, kits and assays, housings, inorganic compounds, amino acid derivatives, filter discs and membranes, cell lines, test methods and kits, cell culture media and reagents, water purification systems, and filters and holders and accessories for health care. The company was founded in 1954 and is headquartered in Darmstadt, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Human Resources Officer | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BÂLOISE HOLDING AG | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Undergraduate Degree Graduate Degree | |
| BASF SE | Electrical Products | Corporate Officer/Principal Corporate Officer/Principal | |
| ANTERIS TECHNOLOGIES LTD | Medical Specialties | Chief Executive Officer Chief Operating Officer | |
| University of Geneva | College/University | Doctorate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Technische Universität München | College/University | Doctorate Degree Corporate Officer/Principal | |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Other | Founder Founder | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| École Polytechnique Fédérale de Lausanne | College/University | President Graduate Degree | |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
WayPoint Capital LLC
 WayPoint Capital LLC Investment ManagersFinance WayPoint Capital LLC provides professional, scientific and technical services. The company was founded in 2011 and is headquartered in Spokane, WA. | Investment Managers | Chief Tech/Sci/R&D Officer | |
Wellington Management Co. LLP (Private Equity)
 Wellington Management Co. LLP (Private Equity) Investment ManagersFinance Wellington Management Co. LLP (Private Equity) (Wellington Management) is a private equity firm, a subsidiary of Wellington Management Co. LLP founded in 1933. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| CHECKMATE PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member | |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin | |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Investment Managers | Private Equity Investor | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member | |
Affidea Group BV
 Affidea Group BV Medical/Nursing ServicesHealth Services Affidea Group BV provides diagnostic and renal care services. It is a medical service provider that offers diagnostic investigations, renal care, clinical laboratories, cancer treatment, and teleradiology services. The firm also operates centers for dialysis, diagnostic, and cancer treatment purposes. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Corporate Officer/Principal | |
Forestay Capital SA
 Forestay Capital SA Investment ManagersFinance Forestay Capital SA (Forestay Capital) is a venture capital subsidiary of Waypoint Capital Holdings (Jersey) Ltd founded in 2017. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Investor | |
Chamber of Commerce of The United States of America
 Chamber of Commerce of The United States of America Miscellaneous Commercial ServicesCommercial Services The Chamber of Commerce of The United States of America provides information on how businesses can adapt their workforce development and management strategies to deal with the changing labor market. The non-profit company is based in Washington and has subsidiaries in the United States. The Chamber of Commerce of The United States of America is the world's largest business organization, advocating, connecting, informing, and fighting for business growth and success. The American company was founded by Michael Scown, and Suzanne P. Clark has been the CEO of the company since 2014. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Merck (Pty) Ltd.
 Merck (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck (Pty) Ltd. is a South African company that manufactures and distributes pharmaceutical products. The company is based in Modderfontein, South Africa. | Pharmaceuticals: Major | Director of Finance/CFO |
Statistiche
Distribuzione geografica
| Stati Uniti | 25 |
| Svizzera | 11 |
| Germania | 7 |
| Regno Unito | 4 |
| Paesi Bassi | 3 |
Settori
| Health Technology | 25 |
| Consumer Services | 11 |
| Finance | 7 |
| Commercial Services | 5 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 212 |
| Corporate Officer/Principal | 151 |
| Chief Executive Officer | 56 |
| Chairman | 49 |
| Independent Dir/Board Member | 36 |
Contatti più connessi
| Insiders | |
|---|---|
| Patrick Aebischer | 34 |
| Elmar Schnee | 31 |
| Wolfgang Heinz Büchele | 28 |
| Nilesh Kumar | 26 |
| Stefan Oschmann | 23 |
| Simon Sturge | 20 |
| Paris Panayiotopoulos | 18 |
| Arend Oetker | 18 |
| Udit Batra | 16 |
| Luc Bauer | 16 |
| Jean-Paul Mangeolle | 16 |
| Lynne Sullivan | 16 |
| Aymeric Sallin | 14 |
| Allene Diaz | 14 |
| Matthias Zachert | 14 |
- Borsa valori
- Insiders
- Kostas Kaloulis
- Connessioni Società
